Clinical and Laboratory Biomarkers as Predictors of Severity in Pediatric Inflammatory Multisystem Syndrome-temporally Associated With SARS-CoV-2: Data From a Prospective Nationwide Surveillance Study in Switzerland.
Juliane WurmAnita UkaMichael BuettcherLisa KottanattuNina SchöbiJohannes TrückReto VilligerNicole RitzPetra Zimmermannnull nullPublished in: The Pediatric infectious disease journal (2024)
The severity of PIMS-TS may be predicted using clinical symptoms and laboratory biomarkers, which help clinicians in decision-making and management of patients.